Skip to content

13F-HR filed by Tri Locum Partners LP

Tri Locum Partners LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 47 holding rows worth $328,339,765.

Accession
0001826434-23-000004
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 47 entries on the cover page, a total value of $328,339,765 stated on the cover page (in dollars after the unit check, H1), rows summing to $328,339,765 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REGENERON PHARMACEUTICALS COM75886F107Stock43,389$35,651,440dollars as filed
WEST PHARMACEUTICAL SVSC INC COM955306105Stock66,830$23,154,590dollars as filed
Abbott Laboratories002824100COM174,802$17,700,451dollars as filed
TANDEM DIABETES CARE INC875372203COM NEW417,448$16,952,563dollars as filed
Eli Lilly and Company532457108COM44,448$15,264,332dollars as filed
CATALENT INC USD 0.01148806102COM225,399$14,810,968dollars as filed
ILLUMINA INC452327109COM62,819$14,608,558dollars as filed
ARK ETF TR00214Q104INNOVATION ETF350,000$14,119,000dollars as filed
SAREPTA THERAPEUTICS INC803607100COM88,961$12,261,495dollars as filed
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO1,327,097$12,156,209dollars as filed
Merck & Co.,Inc.58933Y105COM114,242$12,154,206dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock149,205$9,202,964dollars as filed
Thermo Fisher Scientific Inc.883556102COM15,889$9,157,943dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,012,373$8,959,501dollars as filed
EVOLENT HEALTH INC CL A30050B101Stock268,011$8,696,957dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock221,730$7,935,717dollars as filed
AbbVie,Inc.00287Y109COM49,213$7,843,076dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM76,070$7,397,047dollars as filed
STEVANATO GROUP S P A ORD SHST9224W109Stock277,467$7,186,395dollars as filed
REATA PHARMACEUTICALS INC75615P103CL A67,206$6,110,370dollars as filed
GUARDANT HEALTH INC COM40131M109Stock255,011$5,977,458dollars as filed
Ventyx Biosciences Inc92332V107Common Stock152,842$5,120,207dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM77,048$5,082,086dollars as filed
UNIQURE NVN90064101SHS227,273$4,577,278dollars as filed
INSPIRE MED SYS INC COM457730109Stock17,523$4,101,609dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock275,011$3,657,646dollars as filed
AKERO THERAPEUTICS INC00973Y108COM88,524$3,386,928dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM3,878,484$3,374,281dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock13,845$3,354,090dollars as filed
VIKING THERAPEUTICS INC92686J106COM200,000$3,330,000dollars as filed
BEAM THERAPEUTICS INC07373V105COM107,230$3,283,383dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM133,452$3,069,396dollars as filed
PROMETHEUS BIOSCIENCES INC74349U108COM28,470$3,055,400dollars as filed
IVERIC BIO INC46583P102COM106,711$2,596,279dollars as filed
ROIVANT SCIENCES LTDG76279101SHS344,530$2,542,631dollars as filed
89BIO INC282559103COM157,225$2,394,537dollars as filed
ALTIMMUNE INC02155H200COM NEW528,814$2,231,595dollars as filed
PRAXIS PRECISION MEDICINES I74006W108COM2,488,354$2,013,078dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS97,814$1,964,105dollars as filed
EVOLUS INC30052C107COM160,269$1,355,876dollars as filed
FEMASYS INC31447E105cs126,482$137,233dollars as filed
ANTERO MIDSTREAM CORP COM03676B102Stock11,114$116,586dollars as filed
B2GOLD CORP COM11777Q209Stock19,076$75,159dollars as filed
PARAMOUNT GROUP INC69924R108COM15,008$68,436dollars as filed
EQUITRANS MIDSTREAM CORP NPV294600101COM10,131$58,557dollars as filed
SOUTHWESTERN ENERGY CO845467109COM10,357$51,785dollars as filed
UNITI GROUP INC91325V108COM11,370$40,364dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001826434-23-000004this filing2023-05-15acceptance time not in the bulk data set